LONDON--(BUSINESS WIRE)--

One of the fastest evolving segments of the IVD industry worldwide and in France in particular, the microbiology testing market is also the greatest challenge faced by suppliers today. The ongoing spread of AIDS, threat of bioterrorism, advances in molecular diagnostic technologies, and wider availability of immunosuppressive drugs are some of the major forces driving the market. Further, recent breakthroughs in gene engineering and detection technologies are creating capturing opportunities for highly sensitive, specific and cost-effective products.

New research study 2013 French Hospital Microbiology Testing Market drawn up by Venture Planning Group (VPG) provides an in-depth investigation of the French hospital microbiology testing market.

The report starts with the coverage of todays scientific views on the definition, epidemiology and etiology of major infectious diseases and microorganisms. It further proceeds with the analysis of volume and sales forecasts for 80 microbiology tests; sales and market shares of the top microbiology product suppliers by test; emerging diagnostic technologies with their potential market applications. The research also discusses opportunitiesinnew product development, reviews instrumentation technologies as well as compares features of the leading analyzers. In addition, the study profiles 32 existent and emerging suppliers, examines biz-opps and offers strategic recommendations.

Report Details:

Title: 2013 French Hospital Microbiology Testing Market

Published: January, 2013

Pages: 897

Price: US$ 4,450.00

http://marketpublishers.com/report/in_vitro_diagnostics/microbiology-virology/2013-french-hospital-microbiology-testing-market.html

Excerpt from:
France Hospital Microbiology Testing Sector Analyzed in New Cutting-Edge VPG Study Published at Marketpublishers.com